Dose assessment of staff and radiation protection in the operating theatre during low dose rate (LDR) brachytherapy for prostate cancer

Ruf V.; Fels F.; Momm F.; Grossmann J. G.; Steurer R.; Okonkwo E.

首页> 外文期刊>Strahlentherapie und Onkologie >Dose assessment of staff and radiation protection in the operating theatre during low dose rate (LDR) brachytherapy for prostate cancer

【24h】

Dose assessment of staff and radiation protection in the operating theatre during low dose rate (LDR) brachytherapy for prostate cancer

机译：低剂量率（LDR）近级术治疗期间，在手术室中的工作人员和辐射保护剂量评估

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Strahlentherapie und Onkologie》 |2019年第1期|共1页
作者
Ruf V.; Fels F.; Momm F.; Grossmann J. G.; Steurer R.; Okonkwo E.;
展开▼
作者单位

KTE GmbH Duale Hsch Baden Wurttemberg Karlsruhe Germany;

Ortenau Klinikum Offenburg Offenburg Germany;

Ortenau Klinikum Offenburg Offenburg Germany;

Ortenau Klinikum Offenburg Offenburg Germany;

Ortenau Klinikum Offenburg Offenburg Germany;

Ortenau Klinikum Offenburg Offenburg Germany;

展开▼
收录信息
原文格式 PDF
正文语种 ger
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Dose assessment of staff and radiation protection in the operating theatre during low dose rate (LDR) brachytherapy for prostate cancer [J] . Ruf V., Fels F., Momm F., Strahlentherapie und Onkologie . 2019,第Suppla1期

机译：低剂量率（LDR）近级术治疗期间，在手术室中的工作人员和辐射保护剂量评估
2. Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer [J] . Nobumichi Tanaka, Isao Asakawa, Kiyohide Fujimoto, BMC Urology . 2012,第1期

机译：在接受低剂量率近距离放射治疗（LDR-近距离放射治疗）的前列腺癌患者中，尿道的最小剂量百分比（占尿道的90％）（UD90）是PSA反弹的最重要预测指标
3. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time [J] . Marisa A. Kollmeier, Sean McBride, Amandeep Taggar, Brachytherapy . 2017,第6期

机译：明确放射治疗后复发性前列腺癌的抢救：低剂量率和高剂量速率近距离放射治疗的比较及前列腺特异性抗原倍增时间的重要性
4. Evaluation of Deformable Image Registration Between High Dose Rate Brachytherapy and Intensity Modulated Radiation Therapy for Prostate Cancer [C] . Noriomi Yokoyama, Akihiro Takemura, Hironori Kojima World Congress on Medical Physics and Biomedical Engineering . 2019

机译：高剂量速率近距离放射治疗与强度调制放射治疗前列腺癌的可变形图像配准评价
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. Minimal percentage of dose received by 90 of the urethra (UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer [O] . Nobumichi Tanaka, Isao Asakawa, Kiyohide Fujimoto, 2012

机译：在接受低剂量率近距离放射疗法（LDR-近距离放射疗法）治疗的前列腺癌患者中尿道最小剂量（占尿道的90％）（％UD90）是PSA反弹的最重要预测指标
7. Minimal percentage of dose received by 90 of the urethra (UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer [O] . 2012

机译：在接受低剂量率近距离放射疗法（LDR-近距离放射疗法）治疗的前列腺癌患者中，尿道最小剂量（占尿道的90％）（％UD90）是PSA反弹的最重要预测指标
8. Use of BEIR V and UNSCEAR 1988 in radiation risk assessment: Lifetime total cancer mortality risk estimates at low doses and low dose rates for low-LET radiation. [R] . 1992

机译：BEIR V和UNsCEaR 1988在辐射风险评估中的应用：低剂量和低LET辐射低剂量率的终生总癌症死亡率风险评估。

Dose assessment of staff and radiation protection in the operating theatre during low dose rate (LDR) brachytherapy for prostate cancer

著录项

相似文献

相关主题

期刊订阅